Small study looks only at a cardiac biomarker; findings are in line with reduced myocarditis risk in mRNA COVID vaccines ...

Discover whether Moderna or BioNTech offers better long-term investment potential as both pivot from COVID-19 to innovative ...

Vaccinations are up this year over last year, but there are enough doses to go around, B.C.'s health ministry says.

The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients by boosting their immune systems ...

Modernas Updated COVID-19 Vaccine Essential Against Emerging Variants KDCA Contracts 2.02 Million Moderna Doses for 2025-2026 ...

The findings revealed that the molecule that powers those specific vaccines, mRNA, has been shown to help the immune system ...

Conflicting advice from federal authorities, medical experts and state associations for the COVID vaccine has jumbled and ...

The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients – revving up their immune ...

The COVID-19 mRNA-based vaccines that saved 2.5 million lives globally during the pandemic could help spark the immune system ...

The researchers found that mRNA-based COVID-19 vaccines could potentially help patients whose tumors don’t respond well to ...

Moderna may look appealing right now, given the company's high cash balance and extensive drug pipeline. However, as Moderna's cash burn dilemma persists, the company's net value will likely keep ...

In earlier laboratory experiments, researchers had observed that mRNA vaccines improve the effectiveness of cancer drugs such ...